Coughlin, J.
Brigham and Women's Hospital · University of Pittsburgh · Pfizer (United States) · Pfizer (United Kingdom) · University of Michigan · UCL Queen Square Institute of Neurology · Janssen Alzheimer Immunotherapy Research & Development (United States) · University College London
2 papers on CoChatORCID 0000-0002-2514-9640
Most cited papers
- Verified
Amyloid-β 11 C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
Liu, E., Schmidt, M. E., Margolin, R., Sperling, R., Koeppe, R., Mason, N. S., Klunk, W. E., Mathis, C. A., Salloway, S., Fox, N. C., et al. (2015) · Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 151
- Verified
Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia
Coughlin, J. M., Ishizuka, K., Kano, S. I., Edwards, J. A., Seifuddin, F. T., Shimano, M. A., Daley, E. L., Zandi, P. P., Leweke, F. M., Cascella, N. G., et al. (2013) · Molecular Psychiatry
Schizophrenia research and treatmentTryptophan and brain disorders
Cited by 66
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free